Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | MITF | O75030 | 1/20 | 0.30 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9660605 | 0.85 | TAAR1 (0.39) | MITFTAAR1 | |
| SCHEMBL9661914 | 0.81 | TAAR1 (0.41) | TAAR1 | |
| SCHEMBL3834096 | 0.80 | TDP1 (0.35) | CA1CA2CA4CA9TDP1 | |
| SCHEMBL9660849 | 0.80 | TAAR1 (0.41) | TAAR1 | |
| SCHEMBL9660870 | 0.79 | TAAR1 (0.32) | TAAR1 | |
| SCHEMBL366506 | 0.79 | CA1 (0.42) | CA1CA2CA4CA9TDP1 | |
| SCHEMBL9660920 | 0.78 | TAAR1 (0.40) | TAAR1 | |
| SCHEMBL9658788 | 0.78 | TAAR1 (0.40) | TAAR1 | |
| SCHEMBL9660125 | 0.78 | TAAR1 (0.40) | TAAR1 | |
| SCHEMBL9660272 | 0.78 | TAAR1 (0.40) | TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7977455-B2 | Analogues of GLP-1 | IPSEN PHARMA, S.A.S. (FR) | 2011-07-12 | — | — | US | disclosed |
| US-20090197802-A1 | Analogues of GLP-1 | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S. (FR) | 2009-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090197802-A1 | Analogues of GLP-1 | GLP1R, IAPP, GIPR | CA1 3428/4885CA2 3330/4885CA4 3104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.